{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,7,20]],"date-time":"2024-07-20T00:19:35Z","timestamp":1721434775830},"reference-count":14,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2024,7,19]]},"DOI":"10.7759\/cureus.64945","type":"journal-article","created":{"date-parts":[[2024,7,19]],"date-time":"2024-07-19T23:41:33Z","timestamp":1721432493000},"source":"Crossref","is-referenced-by-count":0,"title":["Proximal Margin Involvement Following Total Gastrectomy for Seiwert III Adenocarcinoma: A Management Dilemma"],"prefix":"10.7759","author":[{"given":"Rajdave S","family":"Sadu Singh","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Guo H","family":"Loo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Guhan","family":"Muthkumaran","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sekkapan T","family":"Sambanthan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nik","family":"Ritza Kosai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.3390\/cancers15092597","article-title":"Management of esophago-gastric junction carcinoma: a narrative multidisciplinary review","volume":"15","author":"Tondolo V","year":"2023","unstructured":"Tondolo V, Cas\u00e0 C, Rizzo G, et al.. Management of esophago-gastric junction carcinoma: a narrative multidisciplinary review. Cancers (Basel). 2023, 15:2597. 10.3390\/cancers15092597","journal-title":"Cancers (Basel)"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1016\/j.annonc.2022.07.003","article-title":"Oesophageal cancer: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up","volume":"33","author":"Obermannov\u00e1 R","year":"2022","unstructured":"Obermannov\u00e1 R, Alsina M, Cervantes A, et al.. Oesophageal cancer: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up. Ann Oncol. 2022, 33:992-1004. 10.1016\/j.annonc.2022.07.003","journal-title":"Ann Oncol"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2168.1998.00940.x","article-title":"Classification of adenocarcinoma of the oesophagogastric junction","volume":"85","author":"Siewert JR","year":"1998","unstructured":"Siewert JR, Stein HJ. Classification of adenocarcinoma of the oesophagogastric junction. Br J Surg. 1998, 85:1457-9. 10.1046\/j.1365-2168.1998.00940.x","journal-title":"Br J Surg"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1016\/j.jamcollsurg.2019.01.021","article-title":"Short-term outcomes of inflammatory bowel disease after Roux-en-Y gastric bypass vs sleeve gastrectomy","volume":"228","author":"Heshmati K","year":"2019","unstructured":"Heshmati K, Lo T, Tavakkoli A, Sheu E. Short-term outcomes of inflammatory bowel disease after Roux-en-Y gastric bypass vs sleeve gastrectomy. J Am Coll Surg. 2019, 228:893-901. 10.1016\/j.jamcollsurg.2019.01.021","journal-title":"J Am Coll Surg"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1007\/s00261-020-02447-0","article-title":"Clinical impact of FDG PET\/CT in alimentary tract malignancies: an updated review","volume":"45","author":"Akin EA","year":"2020","unstructured":"Akin EA, Qazi ZN, Osman M, Zeman RK. Clinical impact of FDG PET\/CT in alimentary tract malignancies: an updated review. Abdom Radiol (NY). 2020, 45:1018-35. 10.1007\/s00261-020-02447-0","journal-title":"Abdom Radiol (NY)"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.21037\/atm-20-2909","article-title":"New frontiers in esophageal radiology","volume":"9","author":"Schmidlin EJ","year":"2021","unstructured":"Schmidlin EJ, Gill RR. New frontiers in esophageal radiology. Ann Transl Med. 2021, 9:904. 10.21037\/atm-20-2909","journal-title":"Ann Transl Med"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1007\/s10388-023-00993-2","article-title":"Esophageal cancer practice guidelines 2022 edited by the Japan esophageal society: part 1","volume":"20","author":"Kitagawa Y","year":"2023","unstructured":"Kitagawa Y, Ishihara R, Ishikawa H, et al.. Esophageal cancer practice guidelines 2022 edited by the Japan esophageal society: part 1. Esophagus. 2023, 20:343-72. 10.1007\/s10388-023-00993-2","journal-title":"Esophagus"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejso.2018.11.002","article-title":"A meta-analysis on salvage surgery as a potentially curative procedure in patients with isolated local recurrent or persistent esophageal cancer after chemoradiotherapy","volume":"45","author":"Faiz Z","year":"2019","unstructured":"Faiz Z, Dijksterhuis WP, Burgerhof JG, et al.. A meta-analysis on salvage surgery as a potentially curative procedure in patients with isolated local recurrent or persistent esophageal cancer after chemoradiotherapy. Eur J Surg Oncol. 2019, 45:931-40. 10.1016\/j.ejso.2018.11.002","journal-title":"Eur J Surg Oncol"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1186\/s12885-023-11568-w","article-title":"Survival outcomes of esophageal cancer patients with recurrence after curative treatments","volume":"23","author":"Sugawara K","year":"2023","unstructured":"Sugawara K, Oka D, Hara H, Yoshii T, Ushijima H, Kudo S, Fukuda T. Survival outcomes of esophageal cancer patients with recurrence after curative treatments. BMC Cancer. 2023, 23:1051. 10.1186\/s12885-023-11568-w","journal-title":"BMC Cancer"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.21037\/jtd.2017.03.173","article-title":"McKeown or Ivor Lewis totally minimally invasive esophagectomy for cancer of the esophagus and gastroesophageal junction: systematic review and meta-analysis","volume":"9","author":"van Workum F","year":"2017","unstructured":"van Workum F, Berkelmans GH, Klarenbeek BR, Nieuwenhuijzen GA, Luyer MD, Rosman C. McKeown or Ivor Lewis totally minimally invasive esophagectomy for cancer of the esophagus and gastroesophageal junction: systematic review and meta-analysis. J Thorac Dis. 2017, 9:S826-33. 10.21037\/jtd.2017.03.173","journal-title":"J Thorac Dis"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1007\/s10388-023-00984-3","article-title":"Surgical outcomes and quality of life assessment of esophagectomy for cancer with colon conduit via retrosternal route","volume":"20","author":"Long VD","year":"2023","unstructured":"Long VD, Thong DQ, Hai NV, et al.. Surgical outcomes and quality of life assessment of esophagectomy for cancer with colon conduit via retrosternal route. Esophagus. 2023, 20:435-44. 10.1007\/s10388-023-00984-3","journal-title":"Esophagus"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1007\/s00595-011-4513-3","article-title":"Esophageal reconstruction with colon tissue","volume":"41","author":"Yasuda T","year":"2011","unstructured":"Yasuda T, Shiozaki H. Esophageal reconstruction with colon tissue. Surg Today. 2011, 41:745-53. 10.1007\/s00595-011-4513-3","journal-title":"Surg Today"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1186\/s12885-020-07315-0","article-title":"Salvage chemoradiation therapy for recurrence after radical surgery or palliative surgery in esophageal cancer patients: a prospective, multicenter clinical trial protocol","volume":"20","author":"Chang X","year":"2020","unstructured":"Chang X, Deng L, Ni W, et al.. Salvage chemoradiation therapy for recurrence after radical surgery or palliative surgery in esophageal cancer patients: a prospective, multicenter clinical trial protocol. BMC Cancer. 2020, 20:877. 10.1186\/s12885-020-07315-0","journal-title":"BMC Cancer"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2032125","article-title":"Adjuvant nivolumab in resected esophageal or gastroesophageal junction cancer","volume":"384","author":"Kelly RJ","year":"2021","unstructured":"Kelly RJ, Ajani JA, Kuzdzal J, et al.. Adjuvant nivolumab in resected esophageal or gastroesophageal junction cancer. N Engl J Med. 2021, 384:1191-203. 10.1056\/NEJMoa2032125","journal-title":"N Engl J Med"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/261553-proximal-margin-involvement-following-total-gastrectomy-for-seiwert-iii-adenocarcinoma-a-management-dilemma","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,7,19]],"date-time":"2024-07-19T23:41:37Z","timestamp":1721432497000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/261553-proximal-margin-involvement-following-total-gastrectomy-for-seiwert-iii-adenocarcinoma-a-management-dilemma"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,7,19]]},"references-count":14,"URL":"https:\/\/doi.org\/10.7759\/cureus.64945","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2024,7,19]]}}}